Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia
Key Highlights
- ➤Latvia’s first robotic arrhythmia center established at Pauls Stradiņš Clinical University Hospital
- ➤Genesis system successfully treated initial patients with diverse cardiac arrhythmias
- ➤Stereotaxis (STXS) expands Genesis robotic electrophysiology presence into Latvia
Expert Statements
Andrejs Ērglis, Head of the Latvian Cardiology Center at Stradiņš Hospital and Professor of Medicine at the University of Latvia
“The introduction of the advanced Genesis technology at Pauls Stradiņš Clinical University Hospital reflects the hospital’s long-term commitment to developing highly specialized, modern, and patient safety focused healthcare services.”
Andrejs Ērglis, Head of the Latvian Cardiology Center at Stradiņš Hospital and Professor of Medicine at the University of Latvia
“We are proud to make this technology available to the benefit of arrhythmia patients, allowing all patients to benefit from the precision, controlled catheter movement, and safety of robotics.”
Andrejs Ērglis, Head of the Latvian Cardiology Center at Stradiņš Hospital and Professor of Medicine at the University of Latvia
“We particularly see value in our robotic program expanding the potential to treat complex cardiac arrhythmia.”
David Fischel, Chairman and CEO of Stereotaxis
“We are delighted to establish this new robotic electrophysiology center of excellence with Pauls Stradiņš Clinical University Hospital.”
David Fischel, Chairman and CEO of Stereotaxis
“We look forward to collaborating with the hospital and cardiology team to advance patient care in Latvia and advance clinical science that will have a global impact.”
* Pauls Stradiņš Clinical University Hospital installs Genesis Robotic Magnetic Navigation System, establishing the first robotic program for the treatment of cardiac arrhythmia in Latvia * First procedures successfully treated patients with a broad range of arrhythmia ST. LOUIS, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that Pauls Stradiņš Clinical University Hospital in Riga, Latvia, has established the first robotic center for the treatment of cardiac arrhythmias in Latvia and has successfully treated initial patients with the Genesis Robotic Magnetic Navigation System.
“The introduction of the advanced Genesis technology at Pauls Stradiņš Clinical University Hospital reflects the hospital’s long-term commitment to developing highly specialized, modern, and patient safety focused healthcare services,” said Prof. Andrejs Ērglis, Head of the Latvian Cardiology Center at Stradiņš Hospital and Professor of Medicine at the University of Latvia. “We are proud to make this technology available to the benefit of arrhythmia patients, allowing all patients to benefit from the precision, controlled catheter movement, and safety of robotics. We particularly see value in our robotic program expanding the potential to treat complex cardiac arrhythmia.”
Get started
Create a free account to read the full story.